Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities

Yun Chung Leung; SHUM Alisa Sau-wun

Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities

Yun Chung Leung (Inventor)
, SHUM Alisa Sau-wun (Inventor)

Research output: Patents, agreements, assignments and companies › Patents granted

Abstract

This disclosure relates to an arginase albumin-binding domain (ABD) fusion protein and a method for its preparation and use. Methods involving arginine consumption are also provided for the treatment of obesity, metabolic disorders, and related complications and complications.

Original language	English
Patent number	7576262
Filing date	31/05/19
Publication status	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{0f57ffdc7c67482fbfffa05c33787f0f,

title = "Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities",

abstract = "This disclosure relates to an arginase albumin-binding domain (ABD) fusion protein and a method for its preparation and use. Methods involving arginine consumption are also provided for the treatment of obesity, metabolic disorders, and related complications and complications. ",

author = "Leung, \{Yun Chung\} and \{SHUM Alisa Sau-wun\}",

year = "2025",

language = "English",

type = "Patent",

note = "7576262",

}

TY - PAT

T1 - Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities

AU - Leung, Yun Chung

AU - SHUM Alisa Sau-wun,

PY - 2025

Y1 - 2025

N2 - This disclosure relates to an arginase albumin-binding domain (ABD) fusion protein and a method for its preparation and use. Methods involving arginine consumption are also provided for the treatment of obesity, metabolic disorders, and related complications and complications.

AB - This disclosure relates to an arginase albumin-binding domain (ABD) fusion protein and a method for its preparation and use. Methods involving arginine consumption are also provided for the treatment of obesity, metabolic disorders, and related complications and complications.

M3 - Patents granted

M1 - 7576262

Y2 - 2019/05/31

ER -

Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities

Abstract

UN SDGs

Fingerprint

Cite this